Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1995 Oct;103 Suppl 7(Suppl 7):79-82.
doi: 10.1289/ehp.95103s779.

Effects of sex hormones on oncogene expression in the vagina and on development of sexual dimorphism of the pelvis and anococcygeus muscle in the mouse

Affiliations
Review

Effects of sex hormones on oncogene expression in the vagina and on development of sexual dimorphism of the pelvis and anococcygeus muscle in the mouse

T Iguchi et al. Environ Health Perspect. 1995 Oct.

Abstract

Neonatal treatment of female mice with diethystilbestrol (DES) is known to induce ovary-independent persistent proliferation and cornification of vaginal epithelium. This irreversibly changed vaginal epithelium persistently expressed higher levels of c-jun and c-fos mRNAs, which was not altered by postpubertal estrogen. Sexual dimorphism was encountered in mouse pelvis and anococcygeus muscle. Postpubertal estrogen changed the shape of the pelvis to the female type and postpubertal androgen changed it to the male type. Neonatal exposure to DES and to the antiestrogen tamoxifen altered the developmental pattern of the pelvis, which contained lower concentrations of calcium and phosphorus than controls. The size of anococcygeus muscle was increased by postpubertal androgen but decreased by postpubertal estrogen. However, neonatal estrogen (DES) exposure permanently enlarged the anococcygeus muscle. Thus, neonatal treatment of mice with estrogen and antiestrogen results in irreversible changes in nonreproductive as well as reproductive structures.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Endocrinol. 1971 Feb;49(2):243-52 - PubMed
    1. Br J Pharmacol. 1973 Feb;47(2):261-7 - PubMed
    1. Science. 1975 Dec 5;190(4218):991-2 - PubMed
    1. Int Rev Cytol. 1976;44:193-224 - PubMed
    1. Endocrinology. 1977 Jan;100(1):122-7 - PubMed

Publication types

Substances

LinkOut - more resources